Accessibility Menu
 
Merck logo

Merck

(NYSE) MRK

Current Price$113.25
Market Cap$279.37B
Since IPO (1968)+54,817%
5 Year+79%
1 Year+41%
1 Month-6%

Merck Financials at a Glance

Market Cap

$279.37B

Revenue (TTM)

$65.59B

Net Income (TTM)

$8.94B

EPS (TTM)

$3.55

P/E Ratio

31.83

Dividend

$3.32

Beta (Volatility)

0.29 (Low)

Price

$113.25

Volume

302,509

Open

$113.11

Previous Close

$113.25

Daily Range

$112.84 - $114.07

52-Week Range

$73.31 - $125.14

MRK: Motley Fool Moneyball Superscore

79

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Merck

Industry

Pharmaceuticals

Employees

75,000

CEO

Robert M. Davis, MBA

Headquarters

Rahway, NJ 07065, US

MRK Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

28%

Net Income Margin

14%

Return on Equity

37%

Return on Capital

22%

Return on Assets

8%

Earnings Yield

3.14%

Dividend Yield

2.94%

Payout Ratio

92.12%

Stock Overview

Market Cap

$279.37B

Shares Outstanding

2.47B

Volume

302.51K

Avg. Volume

10.41M

Financials (TTM)

Gross Profit

$46.73B

Operating Income

$23.49B

EBITDA

$29.32B

Operating Cash Flow

$16.47B

Capital Expenditure

$4.11B

Free Cash Flow

$12.36B

Cash & ST Invst.

$14.56B

Total Debt

$50.53B

Merck Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$16.29B

+4.3%

Gross Profit

$13.34B

+13.7%

Gross Margin

81.92%

N/A

Market Cap

$279.37B

N/A

Market Cap/Employee

$3.83M

N/A

Employees

73,000

N/A

Net Income

$4.24B

-183.5%

EBITDA

$1.88B

-124.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$43.41B

-69.5%

Accounts Receivable

$12.21B

+13.2%

Inventory

$6.48B

+4.6%

Long Term Debt

$46.67B

+39.4%

Short Term Debt

$2.44B

+79.7%

Return on Assets

8.21%

N/A

Return on Invested Capital

22.09%

N/A

Free Cash Flow

$2.93B

+149.7%

Operating Cash Flow

$3.92B

+56.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AZNAstraZeneca PLC
$181.24-1.21%
NVSNovartis AG
$145.46+0.58%
NVONovo Nordisk A/S
$44.89+1.13%
AMGNAmgen Inc.
$329.43+1.72%

Trending Stocks

Symbol / CompanyPricePrice Chg
DGXXDigi Power X
$5.33+0.35%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.83+0.02%
BLZEBackblaze
$7.63+0.65%
CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF
$8.54-0.05%

Questions About MRK

What is the current price of Merck?

Merck is trading at $113.25 per share.

What is the 52-week range for Merck?

Over the past 52 weeks, Merck has traded between $73.31 and $125.14.

How much debt does Merck have?

As of the most recent reporting period, Merck reported total debt of $49.12B.

How much cash does Merck have on hand?

Merck reported $5.40B in cash and cash equivalents in its most recent financial results.

What is Merck’s dividend yield?

Merck currently has a dividend yield of 2.94%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.